Results 131 to 140 of about 4,832 (178)

Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a <i>post hoc</i> analysis of the ANANKE study. [PDF]

ERJ Open Res
Senna G, Brussino L, Aliani M, Altieri E, Bracciale P, Caiaffa MF, Cameli P, Canonica GW, Caruso C, Centanni S, De Michele F, Del Giacco S, Di Marco F, Malerba L, Menzella F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Vultaggio A, D'Amato M, Caminati M.   +22 more
europepmc   +1 more source

Self-directed de-escalation of maintenance inhaler therapy in patients with severe asthma in remission with biologic treatment: An observational study. [PDF]

J Allergy Clin Immunol Glob
Benfante A, Tomasello A, Catanzaro V, Gentile L, Togias A, Scichilone N.   +5 more
europepmc   +1 more source

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A 32-Week Evaluation.

Int Arch Allergy Immunol
Özden Ş, Tepetam FM, Bozkurt Y, Terzioğlu Şahin F, Aynacı A, Avcı HF, Dursun M, Demirkol MA, Yıldırım N.   +8 more
europepmc   +1 more source

Clinical relevance of CompEx Asthma and impact on disease trajectory: benralizumab effect. [PDF]

ERJ Open Res
Bolton C, Akuthota P, Lugogo N, Barker P, Bengtsson T, Peterson S, Siddiqui S, Da Silva CA.   +7 more
europepmc   +1 more source

The Impact of Obesity on Airway Inflammation, Lung Function and Biologic Treatment in Asthma: A Narrative Review. [PDF]

J Inflamm Res
Hadžić B, Vasbinder EC, Lek RM, Castro Cabezas M, Braunstahl GJ.   +4 more
europepmc   +1 more source

Mirror, mirror on the wall: is CompEx the fairest endpoint of all? [PDF]

ERJ Open Res
Hung CT, Erickson SR, Wu CH.
europepmc   +1 more source

Unmasking EGPA with near fatal diffuse alveolar haemorrhage in severe eosinophilic asthma under treatment with benralizumab: a case report. [PDF]

BMC Pulm Med
Drick N, Kaireit TF, Ruwisch J, Schallhorn S, Bauersachs J, Schenk H, Hoeper MM, Witte T, Seeliger B.   +8 more
europepmc   +1 more source

Real-world outcomes after anti-IL-5/anti-IL-5Rα treatment for hypereosinophilic syndrome: Systematic literature review. [PDF]

J Allergy Clin Immunol Glob
Jain P, Rowell J, Edmonds C, Stokes M, Ding N, Chen SY.   +5 more
europepmc   +1 more source

Safety and efficacy of anti-IL-5 monoclonal antibodies as second-line therapy for chronic rhinosinusitis with nasal polyps: a meta-analysis. [PDF]

Front Immunol
Liao H, Qiu C, Luo Y, Chen J, Qin C, Quan J, Liang W, Qin J, Chen R.   +8 more
europepmc   +1 more source